Maternally-derived antibodies in pups and protection from canine parvovirus infection

被引:62
作者
Decaro, N [1 ]
Campolo, M [1 ]
Desario, C [1 ]
Elia, G [1 ]
Martella, V [1 ]
Lorusso, E [1 ]
Buonavoglia, C [1 ]
机构
[1] Fac Vet Med Bari, Dept Anim Hlth & Wellbeing, I-70010 Bari, Italy
关键词
dog; parvovirus; maternal antibodies; protection;
D O I
10.1016/j.biologicals.2005.06.004
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The interaction between maternally-derived antibodies (MDA) and canine parvovirus (CPV) infection was evaluated in five groups of pups with a wide range of haemagglutination inhibiting (HI) titres of MDA (from < 10 to 320). The pups were inoculated with a field CPV strain and monitored daily to evaluate their clinical condition and viral shedding in the faeces. Serum samples were collected weekly to evaluate antibody response. Clinical signs were observed in dogs with HI titres up to 80. Active CPV replication was demonstrated in dogs with HI titres up to 160, although slightly delayed, at lower titres and for a shorter period compared to seronegative dogs. The successful infection of dogs with HI titres of 80 and 160 was also confirmed by seroconversion, evaluated at day 14 postinfection. These findings are in contrast with the MDA titre (HI >= 80) usually considered fully protective for CPV infection, and suggest the need for revision of current vaccination programmes for pups. (c) 2005 The International Association for Biologicals. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:261 / 267
页数:7
相关论文
共 33 条
[1]   Evidence for evolution of canine parvovirus type 2 in Italy [J].
Buonavoglia, C ;
Martella, V ;
Pratelli, A ;
Tempesta, M ;
Cavalli, A ;
Buonavoglia, D ;
Bozzo, G ;
Elia, G ;
Decaro, N ;
Carmichael, L .
JOURNAL OF GENERAL VIROLOGY, 2001, 82 :3021-3025
[2]  
BUONAVOGLIA C, 1995, MICROBIOLOGICA, V18, P371
[3]  
Buonavoglia C., 1985, Clinica Veterinaria, V108, P19
[4]  
Buonavoglia C., 1994, Journal of Veterinary Medicine Series B, V41, P3, DOI 10.1111/j.1439-0450.1994.tb00199.x
[5]   RESPONSE OF PUPS WITH MATERNAL DERIVED ANTIBODY TO MODIFIED-LIVE CANINE PARVOVIRUS VACCINE [J].
BUONAVOGLIA, C ;
TOLLIS, M ;
BUONAVOGLIA, D ;
PUCCINI, A .
COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES, 1992, 15 (04) :281-283
[6]  
Buonavoglia D, 2000, MICROBIOLOGICA, V23, P93
[7]   PERFORMANCE OF HIGH TITER ATTENUATED CANINE PARVOVIRUS VACCINE IN PUPS WITH MATERNALLY DERIVED ANTIBODY [J].
BURTONBOY, S ;
CHARLIER, P ;
HERTOGHS, J ;
LOBMANN, M ;
WISEMAN, A ;
WOODS, S .
VETERINARY RECORD, 1991, 128 (16) :377-381
[8]  
CARMICHAEL LE, 1994, ANN MED VET, V138, P459
[9]  
CARMICHAEL LE, 1980, AM J VET RES, V41, P784
[10]   Neonatal immunity and immunisation in early age: lessons from veterinary medicine [J].
Chappuis, G .
VACCINE, 1998, 16 (14-15) :1468-1472